Skip to main content
Top
Published in: Supportive Care in Cancer 4/2014

01-04-2014 | Original Article

Patient and oncologist discussions about cancer care costs

Authors: Nora B. Henrikson, Leah Tuzzio, Elizabeth Trice Loggers, Janice Miyoshi, Diana SM Buist

Published in: Supportive Care in Cancer | Issue 4/2014

Login to get access

Abstract

Purpose

Patient out-of-pocket costs are higher for cancer care than for any other health-care sector. Oncologist–patient discussions of costs are not well understood. We conducted an exploratory interview study to examine the frequency, patterns, attitudes, and preferences of both patients and providers on discussion of treatment costs.

Methods

We conducted semi-structured telephone interviews with oncology clinicians and people receiving chemotherapy at a large nonprofit health system. Multiple investigators conducted thematic analysis using modified content analysis, grounded theory, and interaction analysis methods.

Results

Patient themes included the relevance of cost to their experience, preference for the doctor to be the starting point of cost discussions, but relative infrequency of discussions with doctors or other care team member. Provider themes were an emphasis on clinical benefit above costs, conviction that cost-related decisions should rest with patients, and lack of access to treatment costs. Interest in discussing costs and barriers accessing cost information were common themes from both patients and providers.

Conclusions

Doctors and patients want to discuss treatment costs but lack access to them. These data support growing evidence for a provider role in discussions of cost during cancer treatment planning.
Literature
4.
go back to reference Tarn DM, Paterniti DA, Heritage J, Hays RD, Kravitz RL, Wenger NS (2006) Physician communication about the cost and acquisition of newly prescribed medications. Am J Manag Care 12(11):657–664PubMed Tarn DM, Paterniti DA, Heritage J, Hays RD, Kravitz RL, Wenger NS (2006) Physician communication about the cost and acquisition of newly prescribed medications. Am J Manag Care 12(11):657–664PubMed
5.
go back to reference Berry SR, Bell CM, Ubel PA, Evans WK, Nadler E, Strevel EL, Neumann PJ (2010) Continental divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. J Clin Oncol 28(27):4149–4153. doi:10.1200/JCO.2010.29.1625 PubMedCrossRef Berry SR, Bell CM, Ubel PA, Evans WK, Nadler E, Strevel EL, Neumann PJ (2010) Continental divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. J Clin Oncol 28(27):4149–4153. doi:10.​1200/​JCO.​2010.​29.​1625 PubMedCrossRef
8.
go back to reference Dimoska A, Girgis A, Hansen V, Butow PN, Tattersall MH (2008) Perceived difficulties in consulting with patients and families: a survey of Australian cancer specialists. Med J Aust 189(11–12):612–615PubMed Dimoska A, Girgis A, Hansen V, Butow PN, Tattersall MH (2008) Perceived difficulties in consulting with patients and families: a survey of Australian cancer specialists. Med J Aust 189(11–12):612–615PubMed
9.
go back to reference Shrank WH, Joseph GJ, Choudhry NK, Young HN, Ettner SL, Glassman P, Asch SM, Kravitz RL (2006) Physicians’ perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most? Am J Manag Care 12(9):545–551PubMed Shrank WH, Joseph GJ, Choudhry NK, Young HN, Ettner SL, Glassman P, Asch SM, Kravitz RL (2006) Physicians’ perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most? Am J Manag Care 12(9):545–551PubMed
12.
go back to reference Glanz K, Rimer BK, Lewis FM (2008) Health behavior and health education : theory, research, and practice, 4th edn. Jossey-Bass, San Francisco Glanz K, Rimer BK, Lewis FM (2008) Health behavior and health education : theory, research, and practice, 4th edn. Jossey-Bass, San Francisco
13.
go back to reference Charles C, Gafni A, Whelan T (1999) Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 49(5):651–661PubMedCrossRef Charles C, Gafni A, Whelan T (1999) Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 49(5):651–661PubMedCrossRef
14.
go back to reference Neuendorf KA (2001) The content analysis guidebook, 1st edn. Sage, Thousand Oaks Neuendorf KA (2001) The content analysis guidebook, 1st edn. Sage, Thousand Oaks
15.
go back to reference Strauss AL, Corbin JM (1990) Basics of qualitative research: grounded theory procedures and techniques. Sage, Newbury Park Strauss AL, Corbin JM (1990) Basics of qualitative research: grounded theory procedures and techniques. Sage, Newbury Park
16.
go back to reference Bernard HR, Ryan GW (2009) Analyzing qualitative data. Sage, Thousand Oaks Bernard HR, Ryan GW (2009) Analyzing qualitative data. Sage, Thousand Oaks
17.
go back to reference Shankaran V, Jolly S, Blough D, Ramsey SD (2012) Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol 30(14):1608–1614. doi:10.1200/JCO.2011.37.9511 PubMedCrossRef Shankaran V, Jolly S, Blough D, Ramsey SD (2012) Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol 30(14):1608–1614. doi:10.​1200/​JCO.​2011.​37.​9511 PubMedCrossRef
21.
go back to reference Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA, Schnipper LE, American Society of Clinical O (2009) American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 27(23):3868–3874. doi:10.1200/JCO.2009.23.1183 PubMedCrossRef Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA, Schnipper LE, American Society of Clinical O (2009) American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 27(23):3868–3874. doi:10.​1200/​JCO.​2009.​23.​1183 PubMedCrossRef
24.
go back to reference Greene SM, Tuzzio L, Cherkin D (2012) A framework for making patient-centered care front and center. Perm J 16(3):49–53PubMedCentralPubMed Greene SM, Tuzzio L, Cherkin D (2012) A framework for making patient-centered care front and center. Perm J 16(3):49–53PubMedCentralPubMed
26.
go back to reference Epstein RM, Street RL Jr (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering. National Cancer Institute, Bethesda, MD Epstein RM, Street RL Jr (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering. National Cancer Institute, Bethesda, MD
27.
go back to reference Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, Carlsson J, Dahlin-Ivanoff S, Johansson IL, Kjellgren K, Liden E, Ohlen J, Olsson LE, Rosen H, Rydmark M, Sunnerhagen KS (2011) Person-centered care—ready for prime time. Eur J Cardiovasc Nurs 10(4):248–251. doi:10.1016/j.ejcnurse.2011.06.008 PubMedCrossRef Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, Carlsson J, Dahlin-Ivanoff S, Johansson IL, Kjellgren K, Liden E, Ohlen J, Olsson LE, Rosen H, Rydmark M, Sunnerhagen KS (2011) Person-centered care—ready for prime time. Eur J Cardiovasc Nurs 10(4):248–251. doi:10.​1016/​j.​ejcnurse.​2011.​06.​008 PubMedCrossRef
34.
go back to reference Brach C, Keller DL, Hernandez LM, Baur C, Parker R, Dreyer B, Schyve P, Lemerise AJ, Schillinger D (2012) Ten attributes of health literate health care organizations. Institute of Medicine, Washington, D.C. Brach C, Keller DL, Hernandez LM, Baur C, Parker R, Dreyer B, Schyve P, Lemerise AJ, Schillinger D (2012) Ten attributes of health literate health care organizations. Institute of Medicine, Washington, D.C.
36.
go back to reference U.S. Government Accountability Office (2011) Health care transparency: meaningful price information is difficult for consumers to obtain prior to receiving care. U.S. Government Accountability Office, Washington, D.C. U.S. Government Accountability Office (2011) Health care transparency: meaningful price information is difficult for consumers to obtain prior to receiving care. U.S. Government Accountability Office, Washington, D.C.
40.
Metadata
Title
Patient and oncologist discussions about cancer care costs
Authors
Nora B. Henrikson
Leah Tuzzio
Elizabeth Trice Loggers
Janice Miyoshi
Diana SM Buist
Publication date
01-04-2014
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-2050-x

Other articles of this Issue 4/2014

Supportive Care in Cancer 4/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine